ClinicalTrials.gg
RecruitingNCT07383428INICIOUpdated Jul 24, 2026

The INICIO-Guatemala Study

An interventional study of Nutri-INICIO and Mediational Intervention for Sensitizing Caregivers (MISC in Development, Child, sponsored by University of North Carolina, Chapel Hill. Recruiting at 1 site in Guatemala. Open to participants aged 0 Days to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-24.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
0 Days to 50 Years
Sex
All
01

Study summary

The goal of this randomized controlled trial (RCT) is to evaluate an intestinal health-targeted nutritional intervention and a caregiver training program, individually and combined, on childhood neurodevelopment (ND) in rural southwest Guatemala.

The main questions it aims to answer are: what is the impact of an intestinal-targeted nutritional intervention on child ND and what is the added benefit of a caregiver intervention on child ND.

The primary endpoint is the Mullen Scales of Early Learning (MSEL) Early Learning Composite (ELC) Score at 24 months. Secondary endpoints include MSEL subdomain scores (gross motor, fine motor, expressive language, receptive language, visual reception).

Researchers will compare child ND between the four study arms using a factorial design: (1) intestinal health-targeted nutritional intervention, (2) caregiving training program, (3) combined intestinal health-targeted nutritional intervention and caregiving training program, and (4) active control.

Participants will be randomized as mother-child dyads at 6 months of age and followed until 24 months of age.

Read the detailed description

The investigators plan to enroll 400 pregnant women during the second trimester of pregnancy; randomization of mother-child dyads into the four study groups will occur at 6 months of infant age; infants will be followed through 24 months of age. Randomization will occur using a 2×2 factorial design into the four groups. The nutritional intervention, Nutri-INICIO, is a fortified maize-bean-rice bran porridge intended to improve intestinal health and growth. The caregiver intervention, the Mediational Intervention for Sensitizing Caregivers (MISC), consists of twice-monthly, video-feedback-based training sessions from 12-24 months to enhance responsive caregiving.

02

Conditions studied

  • Development, Child

Keywords

  • Nutritional intervention
  • Microbiome
  • Caregiving
  • Rice bran
  • Bean flour
03

In context

Lead sponsor

University of North Carolina, Chapel Hill is the lead sponsor of 1,372 studies on the registry; 133 are open to participants now.

Of its 161 completed or terminated interventional studies of FDA-regulated products, 139 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Days to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

The investigators will offer enrollment to pregnant in the Trifinio region of southwest Guatemala and will enroll their newborns after birth.

Inclusion criteria

Inclusion Criteria:

  • Pregnant woman in the second trimester of pregnancy
  • Pregnant woman =>15 years of age
  • Plan to live in the study area during pregnancy and up to 24 months after giving birth
  • Newborns born to enrolled women will join the study at birth

Exclusion criteria

Exclusion Criteria:

  • Pregnant woman less than 15 years of age
  • Planning to move during the study
  • Not willing or able to participate in the interventions, including following instructions for preparing the food, completing the adherence forms, participating in the caregiving sessions
  • Women who do not sign the consent form for their or their child's participation
  • Infants who require a hospital stay after birth of 21 days or longer
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Outcomes assessor)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    Nutritional Intervention

    Children in this arm will receive the Nutri-INICIO intervention between 6 and 24 months of age.

    Dietary Supplement: Nutri-INICIO

  • Experimental
    Caregiver Intervention

    Caregivers of child participants in this arm will be trained in the Mediational Intervention for Sensitizing Caregivers (MISC) between 12 and 24 months of child age.

    Behavioral: Mediational Intervention for Sensitizing Caregivers (MISC

  • Experimental
    Nutritional Intervention and Caregiver Intervention

    Children in this arm will receive the Nutri-INICIO intervention between 6 and 24 months of age and their caregivers will be trained in the MISC between 12 and 24 months of child age.

    Dietary Supplement: Nutri-INICIO · Behavioral: Mediational Intervention for Sensitizing Caregivers (MISC

  • Active comparator
    Active Control

    Children in this arm will receive the same number of study visits as the experimental groups and will receive essential components of the Minister of Health's childcare package, including micronutrient supplementation.

    Other: Active Control

Interventions

  • Dietary supplementNutri-INICIO

    Nutri-INICIO, is a fortified maize-bean-rice bran porridge intended to improve intestinal health and growth. Caregivers will be instructed on Nutri-INICIO preparation methods. Children 6-11 months old will receive a 20 gram daily serving, children 12-17 months old will receive a 30 gram daily serving, children 18-24 months old will receive a 40 gram daily serving. The investigators will ensure receipt of the essential components of the ministry of health childcare package including micronutrient supplementation and anti-parasite prophylaxis. Participants will also receive anemia screening and treatment as appropriate.

  • BehavioralMediational Intervention for Sensitizing Caregivers (MISC

    The Mediational Intervention for Sensitizing Caregivers (MISC) consists of twice-monthly, video-feedback-based training sessions from 12-24 months to enhance responsive caregiving. The investigators will ensure receipt of the essential components of the ministry of health childcare package including micronutrient supplementation and anti-parasite prophylaxis. Participants will also receive anemia screening and treatment as appropriate.

  • OtherActive Control

    The control group will receive the same number of visits as the experimental groups and the investigators will ensure receipt of the essential components of the ministry of health childcare package including micronutrient supplementation and anti-parasite prophylaxis. Participants will also receive anemia screening and treatment as appropriate.

06

What researchers measure

Primary outcomes

  1. Mullen Scales of Early Learning (MSEL) Early Learning Composite Score (ELC)

    Comprehensive neurodevelopment score, combining scores from the four "cognitive" domains of fine motor, visual reception, receptive language, and expressive language. Z-scores for each of the 4 domains will be calculated by regressing raw score for age. The mean of those four Z-scores will make up the Early Learning Composite Z-score. The score will range from -3 to +3, with the higher score indicating more advanced neurodevelopment.

    Time frame: 24 months of age

Secondary outcomes

  1. Mullen Scales of Early Learning Gross Motor Domain

    The MSEL gross motor domain measures the child's gross motor development. A Z-score will calculated by regressing raw score for age. The score will range from -3 to +3, with the higher score indicating more advanced gross motor development.

    Time frame: 24 months

  2. Mullen Scales of Early Learning Fine Motor Domain

    The MSEL fine motor domain measures the child's find motor development. A Z-score will calculated by regressing raw score for age. The score will range from -3 to +3, with the higher score indicating more advanced fine motor development.

    Time frame: 24 months

  3. Mullen Scales of Early Learning Visual Reception Domain

    The MSEL visual reception domain measures the child's find motor development. A Z-score will calculated by regressing raw score for age. The score will range from -3 to +3, with the higher score indicating more advanced fine motor development.

    Time frame: 24 months

  4. Mullen Scales of Early Learning Receptive Language Domain

    The MSEL receptive language domain measures the child's find motor development. A Z-score will calculated by regressing raw score for age. The score will range from -3 to +3, with the higher score indicating more advanced receptive language development.

    Time frame: 24 months

  5. Mullen Scales of Early Learning Expressive Language Domain

    The MSEL expressive language domain measures the child's find motor development. A Z-score will calculated by regressing raw score for age. The score will range from -3 to +3, with the higher score indicating more advanced expressive language development.

    Time frame: 24 months

07

Study locations

1 of 1 sites recruiting
  • Fundacion para la Salud Integral de los Guatemaltecos
    Coatepeque, Departamento de Quetzaltenango, Guatemala
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified individual data that supports the results will be shared at the time of publication. The data from this study will be made publicly available on the NICHD Data and Specimen Hub (DASH) (https://dash.nichd.nih.gov/) .

Time frame: At the time of publication and will continue to be available for a period of at least 7 years.

Access criteria: The data from this study will be made publicly available on the NICHD Data and Specimen Hub (DASH) (https://dash.nichd.nih.gov/).

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07383428
Responsible party
Sponsor
First posted
Feb 3, 2026
Start date
Jul 2, 2026
Primary completion
Jun 15, 2030 (estimated)
Completion
Jun 15, 2030 (estimated)
Last update
Jul 24, 2026

Study contacts

Neudy Rojop, MPH
Contact
neudy.rojop.fsigcu@gmail.com
+502-3794-4597
Sylvia Becker-Dreps, MD, MPH
principal investigator · University of North Carolina, Chapel Hill
Amy K Connery, PsyD
principal investigator · University of Colorado School of Medicine
Diva Mirella Barrientos Giron, MD
principal investigator · Fundacion para la Salud Integral de los Guatemaltecos

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion